Warning: Declaration of My_Walker::start_el(&$output, $item, $depth, $args) should be compatible with Walker_Nav_Menu::start_el(&$output, $data_object, $depth = 0, $args = NULL, $current_object_id = 0) in /home2/ajnrblog/public_html/ajnrdigest/wp-content/themes/ajnr/functions.php on line 258
Intra- and Extraluminal Structural and Functional Venous Anomalies in Multiple Sclerosis, as Evidenced by 2 Noninvasive Imaging Techniques - AJNR News Digest
March 2013
Expedited Publication

Intra- and Extraluminal Structural and Functional Venous Anomalies in Multiple Sclerosis, as Evidenced by 2 Noninvasive Imaging Techniques

Kresimir Dolic

Kresimir Dolic

We chose to research this topic because CCSVI, from the first moment it was presented, has caused considerable controversy and debate in the medical literature as well as among the population of patients with MS. One of the main criticisms of CCSVI is the uncritical application of interventional procedures in the treatment of CCSVI-related abnormalities without established safety and efficacy outcomes. Furthermore, the origin of CCSVI-related venous anomalies has not been determined, nor has the optimal single imaging modality for showing those abnormalities. In our previous work we also showed that this venous pathology is not  exclusive to patients with MS: healthy controls and patients with other neurological diseases can also present with these anomalies.

We believe that our findings can substantially influence the practice because there is a need for both standardized extracranial and transcranial echo-color Doppler training, which assesses morphologic and/or hemodynamic parameters—basically the form of the veins and the flow within them—in the detection of venous extra- and intracranial abnormalities, as well as a compelling need for multimodal imaging approach studies.

We have been contacted by a number of authors who are interested in understanding the importance of intraluminal and extraluminal abnormalities indicative of CCSVI.

We expanded this research by doing another study in which we investigated the potential risk/protective factors for developing those intraluminal and extraluminal abnormalities in people without neurological diseases. These findings were recently published in Neurological Research (2012;34:819-27) and presented at the 28th European Committee for Treatment and Research in Multiple Sclerosis, Lyon, France, October 10-13, 2012.

Read this article at AJNR.org . . .